Characteristics of SARS-CoV-2 Reinfection and Ancestral RBD-Blocking Antibody Levels: A Cross-Sectional Study in the Post-Zero-COVID Era from Shanghai
Vaccines · 10.06.2026 · 14 (6) · 520
DOI: 10.3390/vaccines14060520 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Vaccines, online erschienen am 10.06.2026. Verfasst von Chen Chen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai 200032, China. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Commission of Shanghai Municipality, Shanghai Municipal Science and Technology Major Project, Shanghai Municipal Health Commission.
Abstract (Originalsprache)
Background
SARS-CoV-2 reinfections increased substantially after the emergence of Omicron variants.
Methods
We conducted a cross-sectional study of 2095 individuals with prior Omicron BA.2 infection in Shanghai, China, during the early post-zero-COVID period. Data on demographics, infection history, and lifestyle factors were collected via questionnaire, and blood samples were obtained for ancestral RBD-blocking antibody measurement.
Results
Meeting WHO physical activity recommendations (≥600 MET-min/week) was associated with lower reinfection odds (OR = 0.59, 95% CI: 0.46–0.74, p < 0.001). The overall median ancestral RBD-blocking antibody level was 263.93 U/mL (IQR: 36.41–331.87). Older age was associated with lower ancestral RBD-blocking antibody levels (β = –0.0038 per year, 95% bootstrap CI: –0.0057 to –0.0019, p < 0.001). All vaccinated groups had significantly higher ancestral RBD-blocking antibody levels than unvaccinated individuals: partially vaccinated (β = 0.4440, 95% CI: 0.1569 to 0.6830, p < 0.001), fully vaccinated (β = 0.8516, 95% CI: 0.7464 to 0.9595, p < 0.001), homologous booster (β = 1.0297, 95% CI: 0.9408 to 1.1223, p < 0.001), and heterologous booster (β = 1.0838, 95% CI: 0.9387 to 1.2226, p < 0.001). Time since last immune event was inversely associated with ancestral RBD-blocking antibody levels (β = –0.0232 per month, 95% CI: –0.0385 to –0.0077, p = 0.0031).
Conclusions
In this cross-sectional study, meeting WHO physical activity recommendations was associated with 41% lower odds of SARS-CoV-2 reinfection, although reverse causality cannot be ruled out. All vaccinated groups had higher ancestral RBD-blocking antibody levels than unvaccinated individuals. Older age and longer time since last immune event were associated with lower ancestral RBD-blocking antibody levels. These associations need confirmation in prospective, well-powered studies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai 200032, China.
- Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), Shanghai Frontiers Science Center of Pathogenic Microorganisms and Infection, School of Basic Medical Sciences, Fudan University, Shanghai 200032, China.
- Minhang District Center for Disease Control and Prevention, Shanghai 201101, China.
- Xietu Street Community Health Service Center, Xuhui District, Shanghai 200032, China.
- Longhua Street Community Health Service Center, Xuhui District, Shanghai 200232, China.
- Shanghai Fifth People's Hospital, Fudan University, Shanghai 200240, China.
ORCID-Profile: Qiao Wang
Förderung
- Science and Technology Commission of Shanghai Municipality
- Shanghai Municipal Science and Technology Major Project
- Shanghai Municipal Health Commission
Zitieren
APA
Chen, C., Zhu, Y., Wang, H., Wu, F., Xie, Y., Jia, Q., Yang, Y., Lyu, J., Qu, J., Wang, Q., & Wu, F. (2026). Characteristics of SARS-CoV-2 Reinfection and Ancestral RBD-Blocking Antibody Levels: A Cross-Sectional Study in the Post-Zero-COVID Era from Shanghai. Vaccines, 14(6), 520. https://doi.org/10.3390/vaccines14060520
Vancouver
Chen C, Zhu Y, Wang H, Wu F, Xie Y, Jia Q, et al. Characteristics of SARS-CoV-2 Reinfection and Ancestral RBD-Blocking Antibody Levels: A Cross-Sectional Study in the Post-Zero-COVID Era from Shanghai. Vaccines. 2026;14(6):520. doi:10.3390/vaccines14060520
BibTeX
@article{Chen2026,
author = {Chen, Chen and Zhu, Yuanfei and Wang, Huiting and Wu, Fei and Xie, Youhua and Jia, Qingqing and Yang, Yang and Lyu, Jiangjiang and Qu, Junqiang and Wang, Qiao and Wu, Fan},
title = {Characteristics of SARS-CoV-2 Reinfection and Ancestral RBD-Blocking Antibody Levels: A Cross-Sectional Study in the Post-Zero-COVID Era from Shanghai},
journal = {Vaccines},
year = {2026},
volume = {14},
number = {6},
pages = {520},
doi = {10.3390/vaccines14060520}
}
EUVIMED